Related Experiment Video

Updated: Aug 17, 2026

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay
10:28

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Published on: January 8, 2012

Study and treatment of gestational trophoblastic diseases at the John I. Brewer Trophoblastic Disease Center,

J R Lurain1, J J Sciarra

  • 1Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago.

European Journal of Gynaecological Oncology
|January 1, 1991
PubMed

Insights

This study found that chemotherapy effectively treats gestational trophoblastic tumors, achieving a 94% cure rate. Factors like diagnosis and metastasis significantly impact treatment outcomes for these rare cancers.

Area of Science:

  • Gynecology
  • Oncology
  • Medical Research

Background:

  • Gestational trophoblastic tumors (GTTs) are rare neoplasms arising from placental tissue.
  • Early diagnosis and effective chemotherapy are crucial for successful GTT management.
  • The John I. Brewer Trophoblastic Disease Center has a long history of managing GTTs.

Purpose of the Study:

  • To evaluate the long-term efficacy of chemotherapy for GTTs.
  • To identify factors influencing treatment response in patients with GTTs.
  • To assess cure rates based on disease stage and characteristics.

Main Methods:

  • Retrospective analysis of 564 patients treated with chemotherapy for GTTs (choriocarcinoma, invasive mole) from 1962-1989.
  • Data collection on patient demographics, tumor type, metastatic sites, and treatment history.
  • Statistical analysis to determine cure rates and identify prognostic factors.

Main Results:

  • An overall cure rate of 94% was achieved for patients treated with chemotherapy.
  • Patients without metastases had a 100% cure rate, while those with metastatic disease had an 85% cure rate.
  • Choriocarcinoma diagnosis, non-lung/vagina metastases, number of metastases, and prior failed chemotherapy significantly influenced treatment response.

Conclusions:

  • Chemotherapy is a highly effective treatment for gestational trophoblastic tumors.
  • Disease stage, specific metastatic sites, and treatment history are critical determinants of patient outcomes.
  • Continued research and specialized centers are vital for optimizing GTT management.

More Related Videos

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos08:50

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Published on: June 12, 2020

Purification of HLA-G+ Extravillous Trophoblasts from Human Term Placental Tissues for Phenotyping and Functional Analysis10:13

Purification of HLA-G+ Extravillous Trophoblasts from Human Term Placental Tissues for Phenotyping and Functional Analysis

Published on: March 13, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...